GoodRx Q1 2026 Earnings EPS Misses Estimates Yet Stock Gains 352 LFUS Q1 2026 Earnings Strong EPS Beat Exceeds Analyst Expectations BUD Q1 2026 Earnings EPS Surpasses Estimates Amid Operational Focus HRTX Q1 2026 Earnings EPS Miss Weighs but Stock Gains Slightly PLOW Q1 2026 Earnings Massive EPS Beat Drives Shares Higher Halozyme Therapeutics HALO Q1 2026 Earnings EPS Beat Highlights Strong Operational Execution